RecruitingNCT06600945
Atracurium Versus Atracurium and Magnesium Sulphate As Adjuvants to Local Anesthetic
Atracurium Versus Atracurium and Magnesium Sulphate As Adjuvants to Local Anesthetic for Peribulbar Anesthesia in Cataract Surgery
Sponsor
Dalia yousry Mohamed elsayed
Enrollment
180 participants
Start Date
Feb 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate the effects of adding magnesium sulfate to atracurium with local anesthetic mixture on akinesia of globe and eyelid regarding onset and duration in cataract surgery using peribulbar technique
Eligibility
Min Age: 20 YearsMax Age: 80 Years
Inclusion Criteria2
- Patients undergoing elective cataract surgery (phacoemulsification and intraocular lens implantation).
- Patients aged 20-80 years. Both sexes. ASA physical status I\&II.
Exclusion Criteria3
- \- Refusal of the patient to participate in the study. Any disorder of neuromuscular system known from history or clinical examination e.g., Guillarian barre syndrome, Myasthenia gravies and Myopathies.
- Patients are known to have a history of fits. Patients on medication known to interact with neuromuscular blocking drugs as antipyretics (aminoglycosides and tetracyclines), antiarrhythmic (quinidine).
- Local sepsis. Coagulation abnormalities (INR>1.4). High myopia with axial length more than 30 mm or less than 21. Mentally retarded patients and failure of proper communication as in deafness. Morbidly obese patients (BMI>40). Patients with glaucoma (increased IOP>20mmgh). Patients with history of hypersensitivity to study drugs. Very dense or very soft cataract .
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERCataract surgery
With local anesthetic in peribulbar anesthesia
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06600945